Interleukin-1 and cutaneous inflammation: A crucial link between innate and acquired immunity

Journal of Investigative Dermatology

Volumn 114, Issue 3, 2000, Pages 602-608

  Murphy, Jo Ellen ^a   Robert, Caroline ^a   Kupper, Thomas S ^a  

^a HARVARD INSTITUTES OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DEFENSIN; ENDOTOXIN; INTERLEUKIN 1; INTERLEUKIN 1 RECEPTOR; INTERLEUKIN 18 RECEPTOR; OPSONIN;

ANTIGEN SPECIFICITY; ARTICLE; CYTOKINE PRODUCTION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNITY; IMMUNOCHEMISTRY; PRIORITY JOURNAL; PROTEIN CONFORMATION; RECEPTOR GENE; SEQUENCE HOMOLOGY; SIGNAL TRANSDUCTION; SKIN INFLAMMATION;

EID: 0034046786     PISSN: 0022202X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1747.2000.00917.x     Document Type: Article

References (113)

1. Abernathy-Carver KJ, Sampson HA, Picker LJ, Leung DY: Milk-induced eczema is associated with the expansion of T cells expressing cutaneous lymphocyte antigen. J Clin Invest 95:913-918, 1995
2. Adachi O, Kawai T, Takeda K, et al: Targeted disruption of the MyD88 gene results in loss of IL-1 and IL-18-mediated function. Immunity 9:143-150, 1998
3. Alcami A, Smith GL: A mechanism for the inhibition of fever by a virus. Proc Natl Acad Sci USA 93:11029-11034, 1996
4. Alnemri ES, Livingston DJ, Nicholson DW, Salvesen G, Thornberry NA, Wong W, Yuan J: Human ICE-CED-3 protease nomenclature. Cell 87:123-130, 1996
5. Alon R, Rossiter H, Wang X, Springer TA, Kupper TS: Distinct cell surface ligands mediate T lymphocyte attachment and rolling on P and E selectin under physiological flow. J Cell Biol 127:1485-1495, 1994
6. Auphan N, DiDonato JA, Rosette C, Helmberg A, Karin M: Immunosuppression by glucocorticoids: inhibition of NF-kappa B activity through induction of I kappa B synthesis. Science 270:286-290, 1995
7. Baker B, Zambryski P, Staskawicz B, Dinesh-Kumar S: Signaling in plant-microbe interactions. Science 276:726-733, 1997
8. Belvin MP, Anderson KV: A conserved signaling pathway: the Drosophila toll-dorsal pathway. Ann Rev Cell Devel Biol 12:393-416, 1996
9. Bergers G, Reikerstorfer A, Braselmann S, Graninger P, Busslinger M: Alternative promoter usage of the Fos-responsive gene Fit-1 generates mRNA isoforms coding for either secreted or membrane-bound proteins related to the IL-1 receptor. EMBO J 13:1176, 1994
10. Bigler CF, Norris DA, Weston WL, Arend WP: Interleukin-1 receptor antagonist production by human keratinocytes. J Invest Dermatol 98:38-44, 1992
11. Black RA, Kronheim SR, Cantrell M, et al: Generation of biologically active interleukin-1 beta by proteolytic cleavage of the inactive precursor. J Biol Chem 263:9437-9442, 1988
12. Burns K, Martinon F, Esslinger C, et al: MyD88, an adapter protein involved in interleukin-1 signaling. J Biol Chem 273:12203-12209, 1998
13. Butcher EC, Picker LJ: Lymphocyte homing and homeostasis. Science 272:60-66, 1996
14. Cao Z, Xiong J, Takeuchi M, Kurama T, Goeddel DV: TRAF6 is a signal transducer for interleukin-1. Nature 383:443-446, 1996
15. Cella M, Engering A, Pinet V, Pieters J, Lanzavecchia A: Inflammatory stimuli induce accumulation of MHC class II complexes on dendritic cells. Nature 388:782-786, 1997
16. Chaudhary PM, Ferguson C, Nguyen V, et al: Clonging and characterization of two Toll/interleukin 1 receptor-like genes TIL3 and TIL4: Evidence for a mutli-gene receptor family in humans. Blood 91:4020-4027, 1998
17. Colotta F, Re F, Muzio M, et al: Interleukin-1 type II receptor: a decoy target for IL-1 that is regulated by IL-4. Science 261:472-475, 1993
18. Cullinan EB, Kwee L, Nunes P, et al: IL-1 receptor accessory protein is an essential component of the IL-1 receptor. J Immunol 161:5614-5620, 1998
19. Delhase M, Hayakawa M, Chen Y, Karin M: Positive and negative regulation of IkappaB kinase activity through IKKbeta subunit phosphorylation. Science 284:309-313, 1999
20. Dinarello CA: Interleukin-1. Rev Infect Dis 6:51-95, 1984
21. Dinarello CA: Biologic basis for interleukin-1 in disease. Blood 87:2095-2147, 1996
22. Dinarello CA, Novick D, Puren AJ, et al: Overview of Interleukin 18: more than an interferon-γ inducing factor. J Leukoc Biol 63:658-664, 1998
23. Duvic M: Human immunodeficiency virus and the skin: selected controversies. J Invest Dermatol 105:117S-212S, 1995
24. Eisenberg SP, Evans RJ, Arend WP, Verderber E, Brewer MT, Hannum CH, Thompson RC: Primary structure and functional expression from complementary DNA of a human interleukin-1 receptor antagonist. Nature 343:341-346, 1990
25. Fearon DT, Locksley RM: The instructive role of innate immunity in the acquired immune response. Science 272:50-53, 1996
26. Fuhlbrigge RC, Kieffer JD, Armerding D, Kupper TS: Cutaneous lymphocyte antigen is a specialized form of PSGL-1 expressed on skin-homing T cells. Nature 389:978-981, 1997
27. Groves RW, Ross E, Barker JNWN, et al: Effect of in vivo interleukin 1 on adhesion molecule expression in normal human skin. J Invest Dermatol 98:384-387, 1992
28. Groves RW, Sherman L, Mizutani H, Dower SK, Kupper TS: Detection of interleukin-1 receptors in human epidermis. Induction of the type II receptor after organ culture and in psoriasis. Am J Path 145:1048-1056, 1994
29. Groves RW, Giri J, Sims J, Dower SK, Kupper TS: Inducible expression of type 2 IL-1 receptors by cultured human keratinocytes. Implications for IL-1-mediated processes in epidermis. J Immunol 154:4065-4072, 1995a
30. Groves RW, Mizutani H, Kieffer JD, Kupper TS: Inflammatory skin disease in transgenic mice that express high levels of interleukin 1 alpha in basal epidermis. Proc Natl Acad Sci USA 92:11874-11878, 1995b
31. Groves RW, Rauschmayr T, Nakamura K, Sarkar S, Williams IR, Kupper TS: Inflammatory and hyperproliferative skin disease in mice that express elevated levels of the IL-1 receptor (type I) on epidermal keratinocytes. Evidence that IL-1-inducible secondary cytokines produced by keratinocytes in vivo can cause skin disease. J Clin Invest 98:336-344, 1996
32. Hauser C, Saurat J-H, Schmitt A, Jaunin F, Dayer J-M: Interleukin-1 is present in normal epidermis. J Immunol 136:3317-3321, 1986
33. Hirsch E, Irikura VM, Paul SM, Hirsh D: Functions of Interleukin 1 receptor antagonist in gene knockout and overproducing mice. Proc Natl Acad Sci USA 93:11008-11013, 1996
34. Hofmeister R, Wiegmann K, Korherr C, Bernado K, Kronke M, Falk W: Activation of acid sphingomyelinase by interleukin-1 (IL-1) requires the IL-1 receptor accessory protein. J Biol Chem 272:27730, 1997
35. Hoover R, Fraumeni JFJ: Risk of cancer in renal-transplant recipients. Lancet 2:55, 1973
36. Horai R, Asano M, Sudo K, et al: Production of mice deficient in genes for interleukin (IL) -1alpha, IL-1beta, IL-1alpha/beta, and IL-1 receptor antagonist shows that IL-1beta is crucial in turpentine-induced fever development and glucocorticoid secretion. J Exp Med 187:1463-1475, 1998
37. Hoshino K, Tsutsui H, Kawai T, Takeda K, Nakanishi K, Takeda Y, Akira S: Cutting edge: generation of IL-18 receptor-deficient mice: evidence for IL-1 receptor-related protein as an essential IL-18 binding receptor. J Immunol 162:5041-5044, 1999
38. Hoxtell EO, Mandel JS, Murray SS, Schuman LM, Goltz RW: Incidence of skin carcinoma after renal transplantation. Arch Dermatol 113:436-438, 1977
39. Hu Y, Baud V, Delhase M, et al: Abnormal morphogenesis but intact IKK activation in mice lacking the IKKalpha subunit of IkappaB kinase. Science 284:316-320, 1999
40. Huang J, Gao X, Li S, Cao Z: Recruitment of IRAK to the interleukin 1 receptor complex requires interleukin 1 receptor accessory protein. Proc Natl Acad Sci USA 94:12829-12832, 1997
41. Itoh S, Hattori T, Hayashi H, et al: Antiproliferative effect of IL-1 is mediated by p38 mitogen-activated protein kinase in human melanoma cell A375. J Immunol 162:7434-7440, 1999
42. Jakob T, Udey MC: Regulation of E-cadherin-mediated adhesion in Langerhans cell-like dendritic cells by inflammatory mediators that mobilize Langerhans cells in vivo. J Immunol 160:4067-4073, 1998
43. Kanakaraj P, Ngo K, Wu Y, et al: Defective interleukin 18-mediated natural killer and T helper cell type 1 responses in IL-1 receptor-associated kinase (IRAK) -deficient mice. J Exp Med 189:1129-1138, 1999
44. Kirschning CJ, Wesche H, Merrill Ayres T, Rothe M: Human toll-like receptor 2 confers responsiveness to bacterial lipopolysaccharide. J Exp Med 188:2091-2097, 1998
45. Knibbs RN, Craig RA, Natsuka S, Chang A, Cameron M, Lowe JB, Stoolman LM: The fucosyltransferase FucT-VII regulates E-selectin ligand synthesis in human T cells. J Cell Biol 133:911-920, 1996
46. Kobayashi Y, Yamamoto K, Saido T, Kawasaki H, Oppenheim JJ, Matsushima K: Identification of calcium-activated neutral protease as a processing enzyme of human interleukin 1 alpha. Proc Natl Acad Sci USA 87:5548-, 1990
47. Kumar S, Tzimas MN, Griswold DE, Young PR: Expression of ST2, an interleukin-1 receptor homologue, is induced by proinflammatory stimuli. Biochem Biophys Res Comm 235:474, 1997
48. Kupper TS: Immune and inflammatory processes in cutaneous tissues. Mechanisms and speculations [published erratum appears in J Clin Invest 87:753, 1991]. J Clin Invest 86:1783-1789, 1990
49. Kupper TS, Groves RW: The interleukin-1 axis and cutaneous inflammation. J Invest Dermatol 105:62S-66S, 1995
50. Kupper TS, Ballard DW, Chua AO, et al: Human keratinocytes contain mRNA indistinguishable from monocyte interleukin 1 alpha and beta mRNA. Keratinocyte epidermal cell-derived thymocyte-activating factor is identical to interleukin 1. J Exp Med 164:2095-2100, 1986
51. Kyriakis JM, Avruch J: Protein kinase cascades activated by stress and inflammatory cytokines. Bioessays 18:567-577, 1996
52. Labow M, Shuster D, Zetterstrom M, et al: Absence of IL-1 signaling and reduced inflammatory response in IL-1 type 1 receptor-deficient mice. J Immunol 159:2452-2461, 1997
53. Lang D, Knop J, Wesche H, Raffetseder U, Kurrle R, Boraschi D, Martin MU: The type II IL-1 receptor interacts with the IL-1 receptor accessory protein: a novel mechanism of regulation of IL-1 responsiveness. J Immunol 161:6871-6877, 1998
54. Lee RT, Brigges W, Cheng G, Rossiter HB, Libby P, Kupper TS: Mechanical deformation promotes secretion of IL-1α and IL-1 receptor antagonist. J Immunol 159:5084-5088, 1997
55. Lemaitre B, Nicolas E, Michaut L, Reichhart JM, Hoffmann JA: The dorsoventral regulatory gene cassette spatzle/Toll/cactus controls the potent antifungal response in Drosophila adults. Cell 86:973-983, 1996
56. Li Q, Van Antwerp D, Mercurio F, Lee K, Verma I: Severe liver degeneration in mice lacking the IkappaB kinase 2 gene. Science 284:321-325, 1999
57. Luger TA, Stadler BM, Katz SI, Oppenheim JJ: Epidermal cell (keratinocyte) -derived thymocyte-activating factor (ETAF). J Immunol 127:1493-1498, 1981
58. Maier JAM, Statuto M, Ragnotti G: Endogenous interleukin-1 alpha must be transported to the nucleus to exert its activity in human endothelial cells. Mol Cell Biol 14:1845-1851, 1994
59. Malinin NL, Boldin MP, Kovalenko AV, Wallach D: MAP3K-related kinase involved in NF-kappaB induction by TNF, CD95 and IL-1. Nature 385:540-544, 1997
60. Marmiroli S, Bavelloni A, Faenza I, et al: Phosphatidylinositol 3-kinase is recruited to a specific site in the activated IL-1 receptor I. FEBS Lett 438:49-54, 1998
61. Masamune A, Igarashi Y, Hakomori S: Regulatory role of ceramide in interleukin (IL) -1 beta- induced E-selectin expression in human umbilical vein endothelial cells. Ceramide enhances IL-1 beta action, but is not sufficient for E-selectin expression. J Biol Chem 271:9368-9375, 1996
62. Matthews JS, O'Neill LAJ: Distinct roles for p42/p44 and p38 mitogen-activated protein kinases in the induction of IL-2 by IL-1. Cytokine 11:643-655, 1999
63. May MJ, Ghosh S, Ik B: Kinases. Kinsmen with different crafts. Science 284:271-273, 1999
64. McMahan C, Slack JL, Mosley B, et al: A novel IL-1 receptor, cloned from B cells by mammalian expression, is expressed in many cell types. EMBO J 10:2821-2832, 1991
65. Medzhitov R, Janeway CA Jr: Innate immunity. The virtues of a nonclonal system of recognition. Cell 91:295-298, 1997
66. Medzhitov R, Preston-Hurlburt P, Janeway CA Jr: A human homologue of the Drosophila Toll protein signals activation of adaptive immunity [see comments]. Nature 388:394-397, 1997
67. Mitcham JL, Parnet P, Bonnert TP, et al: T1/ST2 signaling establishes it as a member of an expanding interleukin-1 receptor family. J Biol Chem 271:5777, 1996
68. Mizutani H, Black R, Kupper TS: Human keratinocytes produce but do not process pro-interleukin-1 (IL-1) beta. Different strategies of IL-1 production and processing in monocytes and keratinocytes. J Clin Invest 87:1066-1071, 1991
69. Moody DB, Reinhold BB, Guy MR, et al: Structural requirements for glycolipid antigen recognition by CD1b-restricted T cells. Science 278:283-286, 1997
70. Morisato D, Anderson KV: Signalling pathways that establish the dorsal-ventral pattern of the Drosophila embryo. Annu Rev Genetics 29:371-399, 1995
71. Mosley B, Urdal DL, Prickett KS, et al: The interleukin-1 receptor binds the human interleukin-1a precursor but not the interleukin-1b precursor. J Biol Chem 262:2941-2944, 1987
72. Muzio M, Ni J, Feng P, Dixit VM: IRAK (Pelle) family member IRAK-2 and MyD88 as proximal mediators of IL-1 signaling. Science 278:1612-1615, 1997
73. Ninomiya-Tsuji J, Kishimoto K, Hiyama A, Inoue J, Cao Z, Matsumoto K: The kinase TAK1 can activate the NIK-I kappaB as well as the MAP kinase cascade in the IL-1 signalling pathway. Nature 398:252-256, 1999
74. Norris JL, Manley JL: Functional interactions between the pelle kinase, Toll receptor, and tube suggest a mechanism for activation of dorsal. Genes Dev 10:862-872, 1996
75. O'Neill LAJ, Greene C: Signal transduction pathways activated by the IL-1 receptor family: ancient signaling machinery in mammals, insects, and plants. J Leukoc Biol 63:650-657, 1998
76. Picker LJ, Michie SA, Rott LS, Butcher EC: A unique phenotype of skin-associated lymphocytes in humans. Preferential expression of the HECA-452 epitope by benign and malignant T cells at cutaneous sites. Am J Pathology 136:1053-1068, 1990
77. Picker LJ, Treer JR, Ferguson-Darnell B, Collins PA, Bergstresser PR, Terstappen LW: Control of lymphocyte recirculation in man. II. Differential regulation of the cutaneous lymphocyte-associated antigen, a tissue-selective homing receptor for skin-homing T cells. J Immunol 150:1122-1136, 1993
78. Picker LJ, Martin RJ, Trumble A, Newman LS, Collins PA, Bergstrasser PR, Leung DYM: Differential expression of lymphocyte homing receptors by human memory/effector T cells in pulmonary versus cutaneous immune effector sites. Eur J Immunol 24:1269-1277, 1994
79. Pitzalis C, Cauli A, Pipitone N, et al: Cutaneous lymphocyte antigen positive T lymphocytes preferentially migrate to skin but not to the joint in psoriatic arthritis. Arthand Rheum 39:137-145, 1996
80. Poltorak A, He X, Smirnova I, et al: Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. Science 282:2085-2088, 1998
81. Rauschmayer T, Groves RW, Kupper TS: Keratinocyte expression of the type 2 interleukin 1 recpetor mediates local and specific inhibition of interleukin 1-mediated inflammation. Proc Natl Acad Sci USA 94:5814-, 1997
82. Reddy SA, Huang JH, Liao WS: Phosphatidylinositol 3-kinase in interleukin 1 signaling. Physical interaction with interleukin 1 receptor and requirement in NFkappaB and AP-1 activation. J Biol Chem 272:29167-29173, 1997
83. Robert C, Fuhlbrigge RC, Keifer JD, et al: Interaction of dendritic cells with skin endothelium: a new perspective on immunosurveillance. J Exp Med 189:627-636, 1999
84. Rock FL, Hardiman G, Timans JC, Kastelein RA, Bazan JF: A family of human receptors structurally related to Drosophila Toll. Proc Natl Acad Sci USA 95:588-593, 1998
85. Rook AH, Heald P: The immunopathogenesis of cutaneous T cell lymphoma. Hematol Oncol Clinic North America 9:997-1010, 1995
86. Rossette C, Karin M: Ultraviolet light and osmotic stress: activation of the JNK cascade through multiple growth factor and cytokine receptors. Science 274:1194-1197, 1996
87. Rossiter H, Alon R, Kupper TS: Selectins. T cell rolling and inflammation. Mol Med Today 3:214-222, 1997
88. Saklatvala J, Dean J, Finch A: Protein kinase cascades in intracellular signalling by interleukin-I and tumour necrosis factor. Biochem Soc Symp 64:63-77, 1999
89. Sauder DN, Carter CS, Katz SI, Oppenheim JJ: Epidermal cell production of thymocyte activating factor (ETAF). J Invest Dermatol 79:34-35, 1982
90. Scheidereit C: Signal transduction. Docking IkappaB kinases. Nature 395:225-226, 1998
91. Scheinman RI, Cogswell PC, Lofquist AK, Baldwin ASJ: Role of transcriptional activation of I kappa B alpha in mediation of immunosuppression. by glucocorticoids. Science 270:283-286, 1995
92. Sizemore N, Leung S, Stark GR: Activation of phosphatidylinositol 3-kinase in response to interlukin-1 leads to phosphorylation and activation of the NF-kappa p65/RelA subunit. Mol Cell Biol 19:4798-4805, 1999
93. Slack J, McMahan CJ, Waugh S, Schooley K, Spriggs MK, Sims JE, Dower SK: Independent binding of interleukin-1 alpha and interleukin-1 beta to type I and type II interleukin-1 receptors. J Biol Chem 268:2513-2524, 1993
94. Spriggs MK, Hruby DE, Maliszewski CR, Pickup DJ, Sims JE, Buller RM, VanSlyke J: Vaccinia and cowpox viruses encode a novel secreted interleukin-1-binding protein. Cell 71:145-152, 1992
95. Springer TA: Traffic signals for lymphocyte recirculation and leukocyte emigration: the multistep paradigm. Cell 76:301-314, 1994
96. Stancovski I, Baltimore D: NF-kB activation: the IkB kinase revealed? Cell 91:299-302, 1997
97. Stevenson FT, Turck J, Locksley RM, Lovett DH: The N-terminal propiece of interleukin 1 alpha is a transforming nuclear oncoprotein. Proc Natl Acad Sci USA 94:508-513, 1997
98. Stylianou E, Saklatvala J: Interleukin 1. Intl J Biochem Cell Biol 30:1075-1079, 1998
99. Symons JA, Eastgate JA, Duff EW: Purification and characterization of a novel soluble receptor for interleukin 1. J Exp Med 174:1251-1254, 1991
100. Takeda K, Takeuchi O, Tsujimura T, et al: Limb and skin abnormalities in mice lacking IKKalpha. Science 284:313-316, 1999
101. Takeuchi O, Hoshino K, Kawai T, et al: Differential roles of TLR2 and TLR4 in recognition of Gram-negative and Gram-positive bacterial cell wall components. Immunity 11:443-451, 1999a
102. Takeuchi O, Kawai T, Sanjo H, et al: TLR6: a novel member of an expanding Toll-like receptor family. Gene 231:59-65, 1999b
103. Thanos D, Maniatis T: NF-kappa B: a lesson in family values. Cell 80:529-532, 1995
104. Thomas JA, Allen JL, Tsen M, et al: Impaired cytokine signaling in mice lacking the IL-1 receptor-associated kinase. J Immunol 163:978-984, 1999
105. Torigoe K, Ushio S, Okura T, et al: Purification and characterization of the human interleukin-18 receptor. J Biol Chem 272:25737-25742, 1997
106. Volpe F, Clatworthy J, Kaptein A, Maschera B, Griffin AM, Ray K: The IL1 receptor accessory protein is responsible for the recruitment of the interleukin-1 receptor associated kinase to the IL1/IL1 receptor I complex. FEBS Lett 419:41-44, 1997
107. Wesche H, Korherr C, Kracht M, Falk W, Resch K, Martin M: The interleukin-1 receptor accessory protein (IL-1RAcP) is essential for IL-1-induced activation of interleukin-1 receptor-associated kinase (IRAK) and stress-activated protein kinases (SAP kinases). J Biol Chem 272:7727-7731, 1997a
108. Wesche H, Henzel WJ, Schillinglaw S, Li S, Cao Z: MyD88: an adaptor that recruits IRAK to the IL-1 receptor complex. Immunity 7:823-847, 1997b
109. Whitham S, Dinesh-Kumar SP, Choi D, Hehl R, Corr C, Baker B: The product of the tobacco mosaic virus resistance gene N. similarity to toll and the interleukin-1 receptor [published erratum appears in Cell 81:466, 1995]. Cell 78:1101-1115, 1994
110. Williams MJ, Rodriguez A, Kimbrell DA, et al: The 18-wheeler mutation reveals complex antibacterial gene regulation in Drosophila host defense. EMBO J 16:6120-6130, 1997
111. Wu LP, Anderson KV: Regulated nuclear import of Rel proteins in the Drosophila immune response. Nature 392:93-97, 1998
112. Yanagisawa K, Takagi T, Tsukamoto T, Tetsuka T, Tominaga SI: Presence of a novel primary response gene ST2L, encoding a product highly similar to the interleukin 1 receptor type 1. FENS Lett 318:83, 1993
113. Yin MJ, Yamamoto Y, Gaynor R: The anti-inflammatory agents aspirin and salicylate inhibit the activity of I (kappa) B kinase-beta. Nature 396:77-80, 1998